Fexofenadine: all 55 studies that test it

Page 1 of 1. Open to participants first (5), then studies with results posted, then the rest; newest registration first within each.

• The Impact of Fexofenadine Hydrochloride on the Prognosis of Patients Post-Acute Myocardial InfarctionRecruitingNCT07381803Phase 3
• Fexofenadine as Adjuvant Therapy in Parkinson DiseaseRecruitingNCT06785298Phase 2/3
• Effect and Safety of Fexofenadine Hydrochloride vs Placebo in Patients With Acute Myocardial Infaction: A Randomized Clinical TrialRecruitingNCT06548204Phase 2
• The Role of Histamine in Muscle Protein Synthesis Following Resistance TrainingRecruitingNCT06152497Not applicable
• Fexofenadine in Patients With Active Rheumatoid ArthritisRecruitingNCT05264025Phase 1/2
• A Placebo-controlled Study of 2-day Pre-treatment With Fexofenadine in Seasonal Allergic RhinitisCompletedNCT05692154Phase 3Results posted
• Effect of Antihistamines on Ureteral Stent-Related SymptomsCompletedNCT04726345Phase 2Results posted
• Fexofenadine Use in Gastroesophageal Reflux SymptomsTerminatedNCT03425097Phase 2Results posted
• Safety Study of Levocetirizine and FexofenadineCompletedNCT01586091Phase 4Results posted
• Do Furanocoumarins Mediate the Fexofenadine-grapefruit Juice Interaction?CompletedNCT01526213Not applicableResults posted
• A Study of Onset of Action of Loratadine and Fexofenadine in Participants With Seasonal Allergic Rhinitis (P08712)CompletedNCT01469234Phase 4Results posted
• Topical Treatment of Under Eye Dark Circles and SwellingCompletedNCT01172522Phase 2Results posted
• Fexofenadine Hydrochloride 180 mg Tablets Under Non-Fasting ConditionsCompletedNCT00835640Phase 1Results posted
• Fexofenadine Hydrochloride 180 mg Tablets Under Fasting ConditionsCompletedNCT00835276Phase 1Results posted
• A Study to Test a New Decongestant in Patients With Allergic Rhinitis Following a Nasal Allergen ChallengeCompletedNCT00562120Phase 2Results posted
• Fluticasone Furoate Nasal Spray Versus Oral FexofenadineCompletedNCT00502775Phase 4Results posted
• Fluticasone Furoate Nasal Spray Versus Oral FexofenadineCompletedNCT00435461Phase 4Results posted
• A Study to Evaluate the Effects of KarXT on the Drug Levels of Midazolam, Fexofenadine, and DigoxinCompletedNCT07118215Phase 1
• Fexofenadine Versus Gabapentin for Uremic Pruritus in Patients on Regular HemodialysisCompletedNCT06466421Phase 4
• Assessment of the Safety, Tolerability and Pharmacokinetics of AV078 in Healthy VolunteersCompletedNCT06205381Phase 1
• Study to Assess Safety and Efficacy of Fexofenadine Hydrochloride (HCL) + Pseudoephedrine HCL Fixed Dose Combination in Indian Male and Female Participants With Allergic Rhinitis (AR) Who Are 12 Years and AboveCompletedNCT05720455Phase 4
• Excipient Effect on Drug Absorption in HumansCompletedNCT04534153Early Phase 1
• Histamine H1/H2 Receptors and Training AdaptationsCompletedNCT04450134Not applicable
• A Drug Interaction Study Between Danicopan and Midazolam, Fexofenadine, and Mycophenolate Mofetil in Healthy ParticipantsCompletedNCT03108274Phase 1
• The Effect Dialysis on the Pharmacokinetics of FexofenadineStatus unknownNCT03078777Phase 4
• Montelukast and Fexofenadine Versus Montelukast and Levocetrizine Combination in Allergic RhinitisCompletedNCT02551536Phase 4
• Evaluation of the Potential Pharmacokinetic Interactions Between Probe Drugs in the Geneva Phenotyping CocktailCompletedNCT02391688Phase 1
• Evaluation of Efficacy of Dellegra in Exposure UnitCompletedNCT02175485Phase 4
• Relative Bioavailability of Dabigatran Etexilate Capsules With and Without Quinidine Sulfate Tablets and to Measure the Effect of Quinidine on the Absorption of Fexofenadine in Healthy Male and Female VolunteersTerminatedNCT02171546Phase 1
• An Open-Label Drug-Drug Interaction Study of Telotristat Etiprate and Fexofenadine in Healthy SubjectsCompletedNCT02157558Phase 1
• Evaluation of the Inhibitory Effect of 5 Anti-Histamines in UrticariaCompletedNCT01940393Phase 4
• Bioequivalence Study of Fexofenadine Hydrochloride Orally Disintegrated Tablets 30 mg Under Fasting ConditionCompletedNCT01888718Phase 1
• Dose Proportionality of Fexofenadine in Healthy Human Egyptian VolunteersCompletedNCT01767272Not applicable
• Fexofenadine HCL - Pseudoephedrine HCL Combination Versus Allegra in Patients With Seasonal Allergic RhinitisCompletedNCT01306721Phase 3
• Safety, Efficacy and Pharmacokinetic Study of Allegra in Pediatric Patients With Atopic Dermatitis (AD)CompletedNCT01244230Phase 2/3
• Safety, Efficacy and Pharmacokinetic Study of Allegra in Pediatric Patients With Perennial Allergic Rhinitis (PAR)CompletedNCT01244217Phase 2/3
• Bioequivalence Study of Fexofenadine HCl 180 mg + Pseudoephedrine HCl 240 mg ER Tablets of Dr.Reddy's Under Fed ConditionsCompletedNCT01133483Phase 1
• Bioequivalence Study of Fexofenadine HCl 180 mg + Pseudoephedrine HCl 240 mg ER Tablets of Dr. Reddy's and Allegra D 24 Hour ER Tablets Under Fasting ConditionsCompletedNCT01133470Phase 1
• Bioequivalence Study of Dr. Reddy's Laboratories Limited Fexofenadine Hydrochloride 180 mg Tablets Under Fed ConditionsCompletedNCT01066767Phase 1
• Bioequivalence Study of Dr.Reddy's Fexofenadine Hydrochloride 180 mg Tablets Under Fasting ConditionsCompletedNCT01066754Phase 1
• Preference for Clarinex Tablets vs Allegra Tablets in Patients With Seasonal Allergies (P03178)CompletedNCT00794768Phase 4
• Preference for Clarinex Tablets vs. Allegra Tablets in Patients With Seasonal Allergies (Study P03179)CompletedNCT00794248Phase 4
• Preference for Clarinex Tablets vs. Allegra Tablets in Patients With Seasonal Allergies (Study P03177)CompletedNCT00783133Phase 4
• Fexofenadine Study On Filipino Children for The Relief of Perennial And Intermittent Allergic RhinitisCompletedNCT00741897Phase 4
• Fasting Study of Fexofenadine Tablets 180 mg and Allegra® Tablets 180 mgCompletedNCT00649376Phase 1
• Food Study of Fexofenadine Tablets 180 mg and Allegra® Tablets 180 mgCompletedNCT00647985Phase 1
• Fexofenadine HCl 180 mg, Montelukast Sodium 10 mg and Placebo in Suppression of Wheal and Flare Induced by Seasonal AllergenCompletedNCT00638118Phase 4
• A Single-Center, Randomized, Double-Blind, Placebo-Controlled, Two-Way Crossover Study Designed to Evaluate the Efficacy of Fexofenadine HCl 180 mg for Preventing and Controlling Cat Allergy SymptomsCompletedNCT00637884Phase 4
• Single-Center, Double-Blind, Randomized , Parallel Study Comparing Onset of Action, Efficacy & Safety of a Single-Dose of Fexofenadine HCl 180 mg vs Montelukast Na 10 mg & Placebo in Treating Seasonal Allergic Rhinitis Subjects in an Allergen Exposure UnitCompletedNCT00637611Phase 4
• Fexofenadine HCl 180 mg, Desloratadine 5 mg and Placebo in Suppression of Wheal and Flare Induced by HistamineCompletedNCT00637585Phase 4
• Single Center, Randomized, Double-Blind,Crossover Study Comparing Effects Of Single-Dose Fexofenadine HCl 180 mg, Cetirizine 10 mg, and Placebo on Cognitive Performance in Naval Flight PersonnelCompletedNCT00637455Phase 4
• Fexofenadine (Allegra®) in Healthy Adults Who Have Been Identified as Slow Metabolizers for DesloratadineCompletedNCT00636870Phase 4
• Fexofenadine in Pruritic Skin DiseaseCompletedNCT00261079Phase 4
• Efficacy and Safety of Fexofenadine in Mild to Moderate Persistent AsthmaCompletedNCT00044824Phase 3
• Efficacy and Safety of Fexofenadine in Mild to Moderate Persistent AsthmaCompletedNCT00044811Phase 3

← Fexofenadine overview